Karrow N A, Guo T L, McCay J A, Johnson G W, Brown R D, Musgrove D L, Germolec D R, Luebke R W, White K L
Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA 23298-6013, USA.
Drug Chem Toxicol. 2001 Aug;24(3):239-58. doi: 10.1081/dct-100103722.
Sodium chlorite is an inorganic by-product of chlorine dioxide formed during the chlorination of drinking water. Relatively little is known about the adverse health effects of exposure to sodium chlorite in drinking water. In this study, we evaluated sodium chlorite's immunomodulatory properties using female B6C3F1 mice and a panel of immune assays that were designed to evaluate potential changes in innate and acquired cellular and humoral immune responses. Female B6C3F1 mice were exposed to sodium chlorite in their drinking water (0, 0.1, 1, 5, 15, and 30 mg/L) for 28 days, and then evaluated for immunomodulation. Overall, minimal toxicological and immunological changes were observed after exposure to sodium chlorite. Increases in the percentages of blood reticulocytes, and the relative spleen weights were both observed at different sodium chlorite treatment levels; however, these increases were not dose-dependent. An increasing trend in the number of spleen antibody-forming cells was observed over the range of sodium chlorite concentrations. This increase was not, however, significant at any individual treatment level, and was not reflected by changes in serum IgM levels. A significant increase (26%) in the total number of splenic CD8+ cells was observed in mice treated with 30 mg/L of sodium chlorite, but not at the other concentrations. Splenic mixed leukocyte response and peritoneal macrophage activity were unaffected by sodium chlorite. Lastly, exposure to sodium chlorite did not affect natural killer cell activity, although a decrease in augmented natural killer cell activity (42%) was observed at the lowest sodium chlorite treatment level. These results suggest that sodium chlorite, within the range 0.1-30 mg/L, produces minimal immunotoxicity in mice.
亚氯酸钠是饮用水氯化过程中形成的二氧化氯的无机副产物。关于饮用水中接触亚氯酸钠对健康的不良影响,人们了解得相对较少。在本研究中,我们使用雌性B6C3F1小鼠和一组免疫测定方法评估了亚氯酸钠的免疫调节特性,这些免疫测定旨在评估先天性和获得性细胞及体液免疫反应的潜在变化。将雌性B6C3F1小鼠置于含有亚氯酸钠(0、0.1、1、5、15和30 mg/L)的饮用水中28天,然后评估其免疫调节情况。总体而言,接触亚氯酸钠后观察到的毒理学和免疫学变化极小。在不同的亚氯酸钠处理水平下,均观察到血液中网织红细胞百分比和脾脏相对重量增加;然而,这些增加并不呈剂量依赖性。在亚氯酸钠浓度范围内,脾脏抗体形成细胞数量呈增加趋势。然而,在任何个体处理水平上,这种增加均不显著,且血清IgM水平的变化也未反映出这一点。在接受30 mg/L亚氯酸钠处理的小鼠中,脾脏CD8 + 细胞总数显著增加(26%),但在其他浓度下未观察到这种情况。亚氯酸钠对脾脏混合淋巴细胞反应和腹腔巨噬细胞活性没有影响。最后,接触亚氯酸钠并未影响自然杀伤细胞活性,尽管在最低亚氯酸钠处理水平下观察到增强的自然杀伤细胞活性有所下降(42%)。这些结果表明,在0.1 - 30 mg/L范围内,亚氯酸钠对小鼠产生的免疫毒性极小。